{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:17:59Z","timestamp":1783577879479,"version":"3.55.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Reliable biomarkers for long-term risk stratification in coronary artery ectasia (CAE) remain limited. The systemic immune-inflammation index (SII), derived from routine hematological parameters, reflects the balance between inflammation and immune status and has demonstrated prognostic value in various cardiovascular conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate whether SII independently predicts major adverse cardiovascular events (MACE) in patients with angiographically confirmed CAE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study at Cangzhou Central Hospital, 200 consecutive patients with CAE were enrolled and followed for a median duration of 30 months. SII was calculated as platelet count\u00d7neutrophil count divided by lymphocyte count. The primary endpoint was MACE, defined as a composite of cardiovascular death, nonfatal myocardial infarction, ischemic stroke, and target vessel revascularization. Receiver operating characteristic (ROC) curve analysis was performed to determine the optimal SII cut-off value. Kaplan\u2013Meier survival analysis and Cox proportional hazards regression models were used to assess the association between SII and outcomes. Incremental predictive value was evaluated by comparing model discrimination and reclassification indices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During follow-up, 18% of patients experienced MACE. Baseline SII levels were significantly higher in patients who developed adverse events. ROC analysis demonstrated good discriminatory ability of SII for predicting MACE (AUC 0.81), with an optimal cut-off value of 645. Kaplan\u2013Meier analysis showed significantly lower event-free survival in patients with high SII levels. In multivariate Cox regression analysis, SII remained independently associated with MACE both as a continuous variable (adjusted HR 1.72 per SD increase) and as a categorical variable (adjusted HR 2.48 for high vs. low SII). Addition of SII to a baseline clinical model significantly improved discrimination (C-statistic increase from 0.72 to 0.83) and enhanced risk reclassification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated systemic immune-inflammation index is an independent predictor of major adverse cardiovascular events in patients with coronary artery ectasia. Incorporation of SII into clinical risk assessment models significantly improves prognostic accuracy, suggesting that this readily available biomarker may serve as a valuable tool for risk stratification in this high-risk population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1839237","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:35:16Z","timestamp":1783575316000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic immune-inflammation Index is an independent risk factor for Major adverse cardiovascular events in patients with coronary artery ectasia"],"prefix":"10.3389","volume":"13","author":[{"given":"Deguang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Coronary Heart Disease 7, Cangzhou Central Hospital","place":["Cangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Coronary Heart Disease 7, Cangzhou Central Hospital","place":["Cangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqing","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Coronary Heart Disease 7, Cangzhou Central Hospital","place":["Cangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Coronary Heart Disease 7, Cangzhou Central Hospital","place":["Cangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Coronary Heart Disease 7, Cangzhou Central Hospital","place":["Cangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Coronary Heart Disease 7, Cangzhou Central Hospital","place":["Cangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e201726","DOI":"10.21542\/gcsp.2017.26","article-title":"Aneurysmal coronary artery disease: an overview","volume":"2017","author":"ElGuindy","year":"2017","journal-title":"Glob Cardiol Sci Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/eurheartj\/ehi725","article-title":"Coronary artery ectasias: imaging, functional assessment and clinical implications","volume":"27","author":"Manginas","year":"2006","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"774597","DOI":"10.3389\/fcvm.2021.774597","article-title":"Is coronary artery ectasia a progressive disease? A self-controlled retrospective cohort study","volume":"8","author":"Liu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.3390\/biomedicines12091984","article-title":"Coronary artery aneurysm or ectasia as a form of coronary artery remodeling: etiology, pathogenesis, diagnostics, complications, and treatment","volume":"12","author":"Wozniak","year":"2024","journal-title":"Biomedicines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.26355\/eurrev_201807_15528","article-title":"Endothelium biomarkers endocan and thrombomodulin levels in isolated coronary artery ectasia","volume":"22","author":"Baysal","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2478\/rjc-2023-0025","article-title":"Isolated coronary artery ectasia presenting as Inferior-posterior stemi\u2014a case-based state-of-the-art review of the current literature","volume":"33","author":"Giuc\u0103","year":"2023","journal-title":"Romanian Journal of Cardiology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1161\/ATVBAHA.117.309683","article-title":"Coronary artery ectasia predicts future cardiac events in patients with acute myocardial infarction","volume":"37","author":"Doi","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/17534259231189195","article-title":"Role of neutrophils in different stages of atherosclerosis","volume":"29","author":"Zhang","year":"2023","journal-title":"Innate Immun"},{"key":"B10","doi-asserted-by":"publisher","first-page":"122617","DOI":"10.1016\/j.lfs.2024.122617","article-title":"Do platelets protect the heart against ischemia\/reperfusion injury or exacerbate cardiac ischemia\/reperfusion injury? The role of pdgf, vegf, and paf","volume":"347","author":"Voronkov","year":"2024","journal-title":"Life Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.3390\/jcm13206249","article-title":"Predictive value of monocyte-to-lymphocyte ratio in differentiating heart failure with reduced ejection fraction in patients with severe aortic stenosis-a retrospective analysis","volume":"13","author":"Olasinska-Wisniewska","year":"2024","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.hpb.2020.03.011","article-title":"The systemic immune-inflammation Index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis","volume":"22","author":"Tsilimigras","year":"2020","journal-title":"HPB (Oxford)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.2147\/JIR.S385990","article-title":"Systemic immune-inflammation Index predicts long-term outcomes in patients with three-vessel coronary disease after revascularization: results from a large cohort of 3561 patients","volume":"15","author":"Zhao","year":"2022","journal-title":"J Inflamm Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3390\/jcm13051256","article-title":"Systemic immune-inflammation Index and systemic inflammatory response Index as predictors of mortality in st-elevation myocardial infarction","volume":"13","author":"Marchi","year":"2024","journal-title":"J Clin Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3000605211016274","DOI":"10.1177\/03000605211016274","article-title":"Systemic immune-inflammation Index as a promising predictor of mortality in patients with acute coronary syndrome: a real-world study","volume":"49","author":"Su","year":"2021","journal-title":"J Int Med Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.5114\/amsad.2021.109253","article-title":"Association of systemic immune-inflammation Index (sii) with presence of isolated coronary artery ectasia","volume":"6","author":"Tosu","year":"2021","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/00365513.2022.2034034","article-title":"Comparison of systemic immune-inflammation Index levels in patients with isolated coronary artery ectasia versus patients with obstructive coronary artery disease and normal coronary angiogram","volume":"82","author":"Esenboga","year":"2022","journal-title":"Scand J Clin Lab Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e20220056","DOI":"10.36660\/abc.20220056","article-title":"Systemic immune inflammation Index is a novel marker in predicting the presence and severity of isolated coronary artery ectasia","volume":"120","author":"Dindas","year":"2023","journal-title":"Arq Bras Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijcard.2008.05.071","article-title":"Pathogenetic mechanisms of coronary ectasia","volume":"130","author":"Antoniadis","year":"2008","journal-title":"Int J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"915081","DOI":"10.3389\/fimmu.2022.915081","article-title":"The roles of neutrophils linking periodontitis and atherosclerotic cardiovascular diseases","volume":"13","author":"Irwandi","year":"2022","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.36660\/abc.20210412","article-title":"Systemic immune-inflammation Index predicts Major cardiovascular adverse events in patients with st-segment elevated myocardial infarction","volume":"119","author":"Saylik","year":"2022","journal-title":"Arq Bras Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/00033197241263399","article-title":"Association between systemic immune-inflammation Index and adverse outcomes in patients with acute coronary syndrome: a meta-analysis","volume":"76","author":"Wang","year":"2025","journal-title":"Angiology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e20230540","DOI":"10.36660\/abc.20230540","article-title":"The relationship between the systemic immune-inflammation Index and ischemia with non-obstructive coronary arteries in patients undergoing coronary angiography","volume":"121","author":"Karakayali","year":"2024","journal-title":"Arq Bras Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/0003319720987743","article-title":"Relationship between systemic immune-inflammation Index (sii) and the severity of stable coronary artery disease","volume":"72","author":"Candemir","year":"2021","journal-title":"Angiology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.cmet.2021.07.001","article-title":"Cardiovascular disease in diabetes, beyond glucose","volume":"33","author":"Eckel","year":"2021","journal-title":"Cell Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/JIR.S568473","article-title":"Systemic immune-inflammation Index outperforms conventional inflammatory markers in predicting cardiovascular outcomes in heart failure with preserved ejection fraction","volume":"19","author":"Zhu","year":"2026","journal-title":"J Inflamm Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3390\/biom15030404","article-title":"Pathological and inflammatory consequences of aging.","volume":"15","author":"Garc\u00eda-Dom\u00ednguez","year":"2025","journal-title":"Biomolecules"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.3390\/jcm12165218","article-title":"Impact of advanced age on the incidence of major adverse cardiovascular events in patients with type 2 diabetes mellitus and stable coronary artery disease in a real-world setting in Spain","volume":"12","author":"Gonz\u00e1lez-Juanatey","year":"2023","journal-title":"J Clin Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1839237\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:35:17Z","timestamp":1783575317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1839237\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":28,"alternative-id":["10.3389\/fcvm.2026.1839237"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1839237","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1839237"}}